RxDoctor Payments Data

Kimberly Dale, APRN

Family · Louisville, KYNPI 1609185628

Payments from drug & device makers

$913in general payments, 2019–2025

Across 58 payments — averaging $15.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$280
  • Pfizer$119
  • GSK$107
  • Novo Nordisk$106
  • AstraZeneca$46
  • Amgen$45
  • plus $211 from 10 others

What the payments were for

  • Food & beverage$913100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$913 in reported general payments places this provider in the 60th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$34,307
Medicare patients
129
Services billed
440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$63,570
JanuviaSitagliptin Phosphate29$35,890
EliquisApixaban13$21,603
JardianceEmpagliflozin11$19,356
FarxigaDapagliflozin Propanediol13$18,388
TradjentaLinagliptin12$10,706
FetzimaLevomilnacipran Hcl11$7,536
SynthroidLevothyroxine Sodium20$1,879
Levothyroxine Sodium171$1,808
Potassium Chloride17$1,693
Atorvastatin Calcium222$1,643
Diclofenac Sodium12$1,420
Albuterol Sulfate HfaAlbuterol Sulfate39$1,215
Rosuvastatin Calcium49$981
Omeprazole57$916

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$106$63,57055 claims
PfizerEliquis$119$21,60313 claims
AstraZenecaFarxiga$46$18,38813 claims
AbbVieFetzima, Synthroid$280$9,41431 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,374 family providers in Kentucky.

Other family in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →